Stacy M. Plum, Ph.D. is SVP of Pharmaceutical Development at Syner-G, bringing 30 years of biotechnology leadership focused on protein and cell-based therapeutics and vaccine development. Since joining Syner-G in 2021, she has advanced biologics programs from discovery through approval using risk-based, phase-appropriate strategies that accelerate development and strengthen regulatory submissions. Stacy has contributed to 20+ IND, IMPD, and BLA submissions, authored 15 scientific publications, 8 patents, and 20+ abstracts, with expertise spanning monoclonal antibodies, fusion proteins, bispecifics, ADCs, gene and cell therapies, and plasma protein therapeutics.